The California Institute for Regenerative Medicine has approved a trio of awards, totaling approximately $4 million, to UC San Diego School of Medicine researchers to advance studies of new stem cell-based treatments for multiple types of cancer and amyotrophic lateral sclerosis.
Related Articles

News
Meddling with Metals: Escaping the Tyranny of Copper
March 4, 2022
sandiegobiotech
News, Syndication
Comments Off on Meddling with Metals: Escaping the Tyranny of Copper
Researchers in the University of California San Diego’s Division of Physical Sciences have reported a new protein-design strategy to sidestep the Irving-Williams Series, allowing other metals to bind to proteins ahead of copper. Click here to view original post… […]

News
Professor of Chemistry Neal Devaraj Named Vannevar Bush Faculty Fellow
July 28, 2022
sandiegobiotech
News, UCSD News
Comments Off on Professor of Chemistry Neal Devaraj Named Vannevar Bush Faculty Fellow
Neal K. Devaraj, professor of chemistry and biochemistry at UC San Diego, has been named a Vannevar Bush Faculty Fellow by the Department of Defense (DOD). Devaraj was one of only nine selected fellows, and the … […]

News
40 Years of Endowed Chairs at UC San Diego
December 9, 2021
sandiegobiotech
News, UCSD News
Comments Off on 40 Years of Endowed Chairs at UC San Diego
Forty years ago, UC San Diego created its first three endowed chairs: the Irwin Mark and Joan Klein Jacobs Chair in Information and Computer Science, the Chair of Judaic Studies, and the Quinn Martin Chair in Dr… […]